Company / R&D per Share
BIOMERICA INC R&D per Share History
FY2016-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$0.06
FY2024
5-year range
$0.06 / $0.15
FY2020-FY2024
Trend
-47.5%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D per Share has declined for 4 consecutive years, from $0.23 in FY2020 to $0.06 in FY2024.
Based on SEC 10-K filings.
0.06 in FY2024 with a 5-year CAGR of -20.3%.
Declined from $0.13 to $0.06 over the past 2 years.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -26.7%
- 5-Year CAGR
- -20.3%
- 10-Year CAGR
- -
Key checks
Key Insights
- BIOMERICA INC's r&d per share has declined for 4 consecutive years.
- In FY2024, r&d per share decreased 47.5% year-over-year.
- Peak r&d per share was recorded in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -6.26 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $0.06 | -47.5% |
| FY2023 | $0.12 | -10.0% |
| FY2022 | $0.13 | -16.6% |
| FY2021 | $0.15 | -31.9% |
| FY2020 | $0.23 | +20.0% |
| FY2019 | $0.19 | -4.2% |
| FY2018 | $0.20 | +15.3% |
| FY2017 | $0.17 | +14.6% |
| FY2016 | $0.15 | +44.5% |
As of FY2024 · SEC Form 10-K · Last checked Jun 22, 2026